| Catalog No. |
Size |
Price |
Figures |
Z02011-1 mg
| 1 mg | $ 420.00 | References:
- Iqbal HS, et al. Evaluation and diagnostic usefulness of domestic and imported enzyme-linked immunosorbent assays for detection of human immunodeficiency virus type 1 antibody in India. Clin. Diagn. Lab. Immunol. Dec 2005; 12(12): 1425-1428.
- Laurie AT, Jackson RM. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics. May 2005; 21(9): 1908-1916.
- Prabu-Jeyabalan M, et al. Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. Apr 2006; 50(4): 1518-1521.
|
|---|
| Full Name | | Human Immunodeficiency Virus (HIV)-2 gp36 Envelope |
|
| Abbreviated Name-1 | HIV-II gp36 envelope |
| Description | Human Immunodeficiency Virus (HIV)-2 gp36 Envelope containing HIV-2 pg36 envelope. Detects all HIV-2 infected individuals responding to HIV-2 envelope proteins. |
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
| Concentration | 1 mg/ml in 50 mM Tris-HCl, 8 M urea, pH 9.0. |
| Stability | Five years frozen. One month in solution at room temperature. |
| Specificity | Immunoreactive with sera of HIV-2 infected individuals. |
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HIV with minimal specificity problems. |